Bone and primary hyperparathyroidism.

Area of Science:

• Endocrinology
• Metabolic Bone Disease

Background:

• Primary hyperparathyroidism (PHPT) is characterized by excessive parathyroid hormone secretion, leading to hypercalcemia.
• Often diagnosed incidentally, PHPT can manifest with cardiovascular, bone, or renal complications, though many patients are asymptomatic.
• Diagnosis can be challenging, especially in normocalcemic PHPT, requiring exclusion of secondary causes.

Purpose of the Study:

• To review the diagnosis and management of primary hyperparathyroidism.
• To highlight the role of parathyroid surgery as the gold standard treatment.
• To discuss alternative medical treatments and post-operative considerations.

Main Methods:

• Literature review of diagnostic criteria for PHPT.
• Analysis of treatment outcomes for parathyroid surgery versus medical management.
• Evaluation of imaging's role in surgical planning.

Main Results:

• Parathyroid surgery is the definitive treatment for PHPT, effectively preventing fractures.
• Medical management is reserved for cases where surgery is contraindicated, with limited efficacy on complications.
• Bisphosphonates should be avoided post-surgery due to potential interference with fracture prevention.

Conclusions:

• Parathyroid surgery is indicated for symptomatic PHPT or those at risk of complications.
• Normocalcemic PHPT diagnosis requires excluding secondary hyperparathyroidism.
• Long-term medical monitoring is essential for patients not undergoing surgery.